UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. _______)*
Kurzweil Applied Intelligence, Inc.
-----------------------------------
(Name of Registrant)
Common Stock, $.01 Par Value
----------------------------
(Title of Class of Securities
50132110
--------
(CUSIP Number)
Gaston Bastiaens
Lernout & Hauspie Speech Products USA, Inc.
20 Burlington Mall Road, Burlington, MA 01803 Telephone: (617) 238-0960
-------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
April 14, 1997
--------------
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with the statement [ ]. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13D
-----------------------
CUSIP NO. 50132110
-----------------------
------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Lernout & Hauspie Speech Products N.V.
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [_]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
SOURCE OF FUNDS*
4
WC
------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
5 PURSUANT TO ITEMS 2(d) or 2(e) [_]
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Belgium
------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 1,639,076 (subject to adjustment)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
0
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 1,639,076 (subject to adjustment)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
1,639,076 (subject to adjustment)
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 [_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
15.3%
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
14
CO
------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
This statement reports the granting by Kurzweil Applied Intelligence, Inc.,
a Massachusetts corporation (the "Registrant") of an option (the "Option")
to Lernout & Hauspie Speech Products N.V., a Belgian corporation (the "Reporting
Entity"), to purchase up to 16% of the outstanding common stock, $0.01 par
value, ("Common Stock") of the Registrant (presently 1,454,076 shares (the
"Option Shares")), pursuant to a Stock Option Agreement (the "Option
Agreement"), dated April 14, 1997, between the Registrant and the Reporting
Entity. The Option Agreement is attached hereto as Exhibit 1 and is
incorporated herein by reference. The exercise of the Option is subject to the
occurrence of certain events relating to attempts by third parties to acquire
the Registrant prior to the effective date of the Merger (as hereinafter
defined). The Registrant and the Reporting Entity have also entered into an
Agreement and Plan of Merger dated as of April 14, 1997 (herein referred to as
the "Merger Agreement"), pursuant to which a wholly-owned subsidiary of the
Reporting Entity will merge into the Registrant (the "Merger") and the
Registrant will become a wholly-owned subsidiary of the Reporting Entity. The
Merger Agreement is attached hereto as Exhibit 2 and is incorporated herein by
reference. This statement also reports the issuance of a warrant (the
"Warrant") to purchase 185,000 shares of Common Stock (the "Warrant Shares") to
a subsidiary of the Reporting Entity pursuant to a Loan Agreement dated April
14, 1997 (the "Loan Agreement").
ITEM 1. SECURITY AND REGISTRANT.
------ -----------------------
This Schedule 13D relates to the shares of Common Stock, $.01 par
value, ("Common Stock"), of the Registrant. The principal executive offices of
the Registrant are located at 411 Waverley Oaks Road, Waltham, MA 02154.
ITEM 2. IDENTITY AND BACKGROUND.
------ -----------------------
(a) This statement is being filed by the Reporting Entity, a Belgian
corporation. The names and citizenship of the executive officers and directors
of the Reporting Entity are set forth on Schedule A attached hereto, which
Schedule is incorporated herein by reference.
(b) The executive offices and principal place of business of the
Reporting Entity are located at Sint-Krispijnstraat 7, 8900 Ieper, Belgium. The
business addresses of the executive officers and directors of the Reporting
Entity are set forth on Schedule A attached hereto, which Schedule is
incorporated herein by reference.
(c) The Reporting Entity is an international developer and licensor of
advanced speech technologies and provider of translation services. The present
principal occupations of the executive officers and directors of the Reporting
Entity are set forth on Schedule A attached hereto, which Schedule is
incorporated herein by reference.
(d) During the last five years, neither the Reporting Entity nor, to
the best of the Reporting Entity's knowledge, any of the Reporting Entity's
directors or executive officers listed on Schedule A have been convicted in a
criminal proceeding (excluding traffic violations or other similar
misdemeanors).
(e) During the last five years, neither the Reporting Entity nor, to
the best of the Reporting Entity's knowledge, any of the Reporting Entity's
directors or executive officers listed on Schedule A has been a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction and,
as a result of such proceeding, was or is subject to a judgment, decree or final
order enjoining future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding any violation with
respect to such laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
------ -------------------------------------------------
The Registrant granted (i) the Reporting Entity the Option in
consideration of the Reporting Entity's entering into the Merger Agreement and
(ii) a subsidiary of the Reporting Entity the Warrant in consideration of a the
subsidiary's entering into the Loan Agreement.
The Option Agreement and the Warrant provide that the consideration
for the Common Stock purchased upon exercise of such instruments shall be
payable in immediately available funds. It is anticipated that any funds used
to purchase Option Shares will be provided by the general working capital of the
Reporting Entity.
ITEM 4. PURPOSE OF TRANSACTION.
------ ----------------------
On April 14, 1997 the Registrant entered into the Merger Agreement
with the Reporting Entity and a wholly-owned subsidiary of the Reporting Entity.
The Agreement provides for the merger of that subsidiary into the Registrant and
for the Registrant to be the surviving corporation. As a result of the Merger,
the Registrant will become a wholly-owned subsidiary of the Reporting Entity.
The closing of the Merger is subject to certain conditions and approvals,
including the approval of the Registrant's stockholders.
Under the terms of the Merger Agreement at the effective time of the
Merger, each share of Common Stock will be converted into and represent the
right to receive $4.20 in cash and a fraction of a share of Reporting Entity
common stock, no par value. The fraction is based on a conversion ratio equal
to $1.05 divided by the average closing price per share of the Reporting
Entity's common stock on the Nasdaq National Market for the ten consecutive
trading days ending with the last trading day prior to the date of the
Registrant's 1997 Annual Meeting of Stockholders, except that the conversion
ratio will be no less than 0.047549 of a share of Reporting Entity common stock
for each share of Common Stock and no more than 0.058115 of a share of Reporting
Entity common stock for each share of Common Stock.
As part of the consideration for the Reporting Entity entering into
the Merger Agreement, the Registrant granted the Reporting Entity the Option
pursuant to the Option Agreement. The Option is for up to 16% of the
Registrant's shares outstanding during the term of the Option (i.e., 1,454,076
shares of Common Stock, subject to adjustment) at a purchase price of $5.25 per
share. The Option is exercisable under certain circumstances in the event of
the termination of the Merger Agreement and the occurrence of certain events
relating to attempts by third parties to acquire the Registrant. The Registrant
has the right to repurchase the Option and any shares purchased under the Option
under certain circumstances.
In connection with execution of the Merger Agreement and pursuant to the
Loan Agreement, the Reporting Entity's United States subsidiary, Lernout &
Hauspie Speech Products USA, Inc., with its principal executive offices located
at 20 Burlington Mall Road, Burlington, MA 01803, has loaned to the Registrant
$1.5 million for working capital purposes. In consideration of this loan, the
Registrant has issued to this subsidiary the Warrant to purchase 185,000 shares
of Common Stock at a purchase price of $3.21 per share.
The foregoing summaries of the Merger Agreement, the Option Agreement, the
Loan Agreement and the Warrant are not intended to be complete statements of all
of the material terms of those agreements. The summaries are qualified in their
entirety by the agreements themselves and related agreements that are filed
herewith as Exhibits 1 through 7.
Except to the extent set forth above, or in any other Item hereof, the
Reporting Entity does not have any plans or proposals that relate to or would
result in any of the actions required to be described in Items 4(a)-(j) of
Schedule 13D.
ITEM 5. INTEREST IN SECURITIES OF THE REGISTRANT.
------ ----------------------------------------
(a) Pursuant to the Option Agreement, the Reporting Entity has the
right to acquire up to 16% of the Registrant's Common Stock (presently 1,454,076
shares of Common Stock), representing approximately 13.8% of the outstanding
Common Stock as of January 31, 1997, after giving effect to the exercise of the
Option. Pursuant to the Warrant, a wholly-owned subsidiary of the Reporting
Entity has the right to acquire up to 185,000 shares of Common Stock,
representing approximately 2.0% of the outstanding Common Stock as of January
31, 1997, after giving effect to the exercise of the Warrant. The Option Shares
and the Warrants Shares, together, represent approximately 15.3% of the
outstanding Common Stock as of January 31, 1997, after giving effect to the
exercise of the Option and the Warrant. The Reporting Entity may be deemed to
be the beneficial owner of the Common Stock subject to the Option and the
Warrant but disclaims beneficial ownership of the Option Shares, because the
Option is exercisable only in certain circumstances, none of which has occurred
as the date hereof.
(b) The Reporting Entity currently has no right to vote or dispose of the
Option Shares or the Warrant Shares. The Reporting Entity will not acquire the
right to vote or dispose of the Option Shares or the Warrant Shares until such
time as it exercises the Option or the Warrant. The Option is not currently
exercisable and will become exercisable only upon the occurrence of certain
events described above under Item 4 (and more fully in the Option Agreement
attached hereto as Exhibit 2) relating to the acquisition, merger, consolidation
or similar extraordinary corporate transaction involving the Registrant and a
party other than the Reporting Entity. The Warrant is currently exercisable. The
Reporting Entity has sole dispositive power as to the Option and the Warrant and
will acquire sole voting and dispositive power as to the underlying Common Stock
only upon exercise of the Option and the Warrant.
(c) Other than as described herein, the Reporting Entity has no knowledge
of any other transaction involving securities of the Registrant effected within
the past 60 days.
(d) So long as the Reporting Entity or its wholly-owned subsidiary, as
applicable, has not purchased the Option Shares or the Warrant Shares, the
Reporting Entity does not have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale of, any of the Option
Shares or the Warrant Shares.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
------ ---------------------------------------------------------------------
TO SECURITIES OF THE REGISTRANT.
-------------------------------
Pursuant to the terms of the Merger Agreement, the Registrant has agreed to
use its reasonable best efforts to obtain and deliver the written agreement (in
the form attached hereto as Exhibit 7) of all executive officers and directors
of the Registrant, to the extent such persons are holders of Common Stock,
irrevocably granting a proxy (coupled with an interest) to the Reporting Entity
or its designee to vote all Common Stock owned by such persons (approximately
17,900 shares of Common Stock) in favor of the Merger Agreement and the
transactions contemplated thereby. Except as set forth under this Item 6 and
elsewhere in this Schedule 13D, there are no contracts, arrangements,
understandings, or relationships (legal or otherwise) among the persons and
entities named in Item 2, or between such persons or entities and any person,
with respect to any securities of the Registrant.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
------ --------------------------------
Exhibit 1 Agreement and Plan of Merger dated April 14, 1997 between
Kurzweil Applied Intelligence, Inc., Lernout & Hauspie Speech
Products N.V. and Trappist Acquisition Corp.**
Exhibit 2 Stock Option Agreement dated April 14, 1997 between Kurzweil
Applied Intelligence, Inc. and Lernout & Hauspie Speech Products
N.V.**
Exhibit 3 Loan Agreement dated April 14, 1997 between Kurzweil Applied
Intelligence, Inc. and Lernout & Hauspie Speech Products USA,
Inc.**
Exhibit 4 Common Stock Warrant dated April 14, 1997 issued by Kurzweil
Applied Intelligence, Inc.**
Exhibit 5 Line of Credit Note dated April 14, 1997.**
Exhibit 6 Security Agreements dated April 14, 1997 between Kurzweil Applied
Intelligence, Inc. and Lernout & Hauspie Speech Products USA,
Inc.**
Exhibit 7 Form of Affiliate Agreement.***
__________________________
** Incorporated by reference from Exhibits 99.2 through 99.7,
respectively, from the Form 8-K (SEC File No. 000-20256) filed on
April 24, 1997 with the Securities and Exchange Commission by Kurzweil
Applied Intelligence, Inc.
*** Filed herewith.
SCHEDULE 13D - SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
May 8, 1997 LERNOUT & HAUSPIE SPEECH
------------------------ PRODUCTS N.V.
(Date)
/s/ Gaston Bastiaens
________________________________
Gaston Bastiaens
President and Chief Executive Officer
SCHEDULE A
OFFICERS AND DIRECTORS OF LERNOUT & HAUSPIE SPEECH PRODUCTS N.V.
----------------------------------------------------------------
The name, business address, present principal occupation or employment, and
the name, principal business address of any corporation or other organization in
which such employment is conducted, of each of the Directors and Executive
Officers of Lernout & Hauspie Speech Products N.V. (the "Reporting Entity") is
set forth below. Unless otherwise indicated, each occupation set forth opposite
an Executive Officer's name refers to employment with the Reporting Entity.
Each of the individuals listed in this Schedule A are citizens of Belgium,
except Robert D. Kutnick and Koen Bouwers, who are citizens of the United States
and the Netherlands, respectively.
NAME PRESENT PRINCIPAL OCCUPATION OR EMPLOYMENT AND
---- ----------------------------------------------
ADDRESS
-------
--------------------------------------------------------------------------------
Jo Lernout Co-Chairman of the Board and Managing Director
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Pol Hauspie Co-Chairman of the Board and Managing Director
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Nico Willaert Vice Chairman and Managing Director
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Gaston Bastiaens President and Chief Executive Officer
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Robert D. Kutnick Senior Vice President and Chief Technology Officer
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Johan Thys Vice President of Operations
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Bart Verhaeghe Vice President of Sales and Marketing
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Koen Bouwers Senior Vice President and President of Dictation
Division
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Florita Mendez Senior Vice President and President of the
Translation Division
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Carl Dammekens Vice President Finance - Belgium and Acting Chief
Financial Officer
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Fernand Cloet Managing Director
Tack N.V.
c/o Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
John Cordier Chairman
Telinfo N.V.
c/o Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Marc G.H. De Pauw General Manager
National Investment Corporation
c/o Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Hubert Detremmerie Director
Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
RVD Securities N.V. Chief Financial Officer
represented by Erwin Icos Vision Systems Incorporated N.V.
Vandendriessche c/o Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Philip Vermeulen Executive Senior Investment Manager for Venture
Capital
GIMV N.V.
c/o Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
Dirk Cauwelier Attorney
c/o Lernout & Hauspie Speech Products N.V.
Sint-Krispijnstraat 7
8900 Ieper, Belgium
--------------------------------------------------------------------------------
EXHIBIT 7
AFFILIATE'S AGREEMENT
This AGREEMENT (this "Agreement") is made as of _____________, 1997, by and
among Lernout & Hauspie Speech Products N.V., a Belgian corporation ( the
"Parent"), and the undersigned stockholder (the "Undersigned") of Kurzweil
Applied Intelligence, Inc., a Delaware corporation (the "Company"). Reference
is made to that certain Agreement and Plan of Merger, dated April ___, 1997 (the
"Merger Agreement"), by and among Parent, Trappist Acquisition Corp., a Delaware
corporation and wholly owned subsidiary of Parent ("Trappist Acquisition"), and
the Company.
WHEREAS, Parent, Trappist Acquisition and the Company are contemplating a
merger of Trappist Acquisition with and into the Company (the "Merger") pursuant
to which the Company will become a wholly owned subsidiary of Parent.
WHEREAS, the Merger is contingent upon the approval of the Merger and the
Merger Agreement by the Company's stockholders, and the Undersigned desires to
facilitate the Merger by agreeing to vote the Undersigned's shares of the
Company's Company Common Stock and any Company Common Stock of the Company over
which the Undersigned has voting control in favor of the Merger and the Merger
Agreement.
WHEREAS, the Undersigned desires to irrevocably appoint Parent or any
designee of Parent as the Undersigned's lawful agent, attorney and proxy to vote
in favor of the Merger and the Merger Agreement.
WHEREAS, in accordance with the Agreement, shares of common stock, $.01 par
value per share, of the Company (the "Company Common Stock") owned by the
Undersigned at the Effective Time (as defined in the Agreement) shall be
converted into a combination of cash and shares of common stock of the Parent
(the "Parent Common Stock"), as described in the Agreement.
NOW, THEREFORE, in consideration of the mutual agreements, provisions and
covenants set forth in the Agreement and hereinafter in this agreement, the
Undersigned represents and agrees as follows:
1. Transfer Restriction. The Undersigned will not sell, transfer or
--------------------
otherwise dispose of, or reduce his or its interest in any shares of Company
Common Stock currently owned or hereafter acquired by him prior to the
termination of this Agreement.
2. Voting Agreement. At a special meeting of the stockholders of the
----------------
Company called for the purpose of considering the approval of the Merger and the
Merger Agreement, the Undersigned (if a director or executive officer of the
Company) agrees to vote all of the Company Common Stock held by the Undersigned
and any of the Company Common Stock over which the Undersigned has voting
control, in favor of the Merger and the Merger Agreement.
3. Irrevocable Proxy. The Undersigned (if a director or executive officer
-----------------
of the Company) hereby irrevocably appoints Parent or any designee of Parent as
the Undersigned's lawful agent, attorney and proxy to vote or give consents with
respect to the shares of Company Common Stock held by the Undersigned and any
shares of Company Common Stock over which the Undersigned has voting control, in
favor of the approval of the Merger and the Merger Agreement. The Undersigned
intends this proxy to be irrevocable and coupled with an interest. Parent
agrees that it or its designee shall vote the shares of Company Common Stock
held by the Undersigned and any shares of Company Common Stock over which the
Undersigned has voting control, in favor of the approval of the Merger and the
Merger Agreement. The agents, attorneys and proxies named herein may not
exercise this proxy on any other matter except as provided herein. The
Undersigned may vote all shares of Company Common Stock held by the Undersigned
and any shares of Company Common Stock over which the Undersigned has voting
control on all other matters.
4. No Shopping. The Undersigned (if a director or executive officer of
-----------
the Company) shall not directly or indirectly (i) solicit, initiate or encourage
(or authorize any person to solicit, initiate or encourage) any inquiry,
proposal or offer from any person (other than Parent) to acquire the business,
property or capital stock of the Company or any direct or indirect subsidiary
thereof, or any acquisition of a substantial equity interest in, or a
substantial amount of the assets of, the Company or any direct or indirect
subsidiary thereof, whether by merger, purchase of assets, tender offer or other
transaction or (ii) subject to the fiduciary duty of the Undersigned as a
director of the Company under applicable law, participate in any discussion or
negotiations regarding, or furnish to any other person any information with
respect to, or otherwise cooperate in any way with, or participate in,
facilitate or encourage any effort or attempt by any person (other than
Parent)to do or seek any of the foregoing.
5. Rule 145. The Undersigned understands that the Undersigned's resale of
--------
Parent Common Stock issued to the Undersigned in the Merger will be subject to
certain restrictions on transfer in accordance with Rule 145 under the
Securities Act of 1933, as amended (the "Securities Act"), and in connection
therewith agrees not to offer, sell, pledge, transfer or otherwise dispose of
any of such shares of Parent Common Stock unless at such time either: (i) such
transaction shall be permitted pursuant to the provisions of Rule 145 under the
Securities Act; (ii) the Undersigned shall have furnished to the Parent an
opinion of counsel, satisfactory to the Parent, to the effect that no
registration under the Securities Act would be required in connection with the
proposed offer, sale, pledge, transfer or other disposition; (iii) a
registration statement under the Securities Act covering the proposed offer,
sale, pledge, transfer or other disposition shall be effective under the
Securities Act; or (iv) an authorized representative of the Securities and
Exchange Commission (the "SEC") shall have rendered written advice to the
Undersigned to the effect that the SEC will take no action, or that the staff of
the SEC will not recommend that the SEC take action, with respect to the
proposed offer, sale, pledge, transfer or other disposition if consummated.
6. Legend. The Undersigned understands that all certificates representing
------
the Parent Common Stock deliverable to the Undersigned pursuant to the Merger
shall, until the occurrence of one of the events referred to in Section 5 above,
bear a legend substantially as follows:
"The shares represented by this certificate may not be offered, sold,
pledged, transferred or otherwise disposed of except in accordance
with the requirements of Rule 145 of the Securities Act of 1933, as
amended."
The Parent, in its discretion and in a manner consistent with the legend
set forth above, may cause stop transfer orders to be placed with its transfer
agent with respect to the certificates for the shares of Parent Common Stock
which are required to bear the foregoing legend.
7. SEC Filings: Information. From and after the Effective Date, and for
------------------------
so long as necessary in order to permit the Undersigned to sell the Parent
Common Stock pursuant to Rule 145, and to the extent applicable, Rule 144 under
the Securities Act, Parent will file on a timely basis all reports required to
be filed by it pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934, referred to in paragraph (c)(1) of Rule 144 under the Securities Act (or,
if applicable, Parent will make publicly available the information regarding
itself referred to in paragraph (c)(2) of Rule 144), in order to permit the
Undersigned to sell, pursuant to the terms and conditions of Rule 145 and the
applicable provisions of Rule 144, any of such shares of Parent Common Stock
held by the Undersigned.
8. Miscellaneous.
-------------
(a) By signing below, the Undersigned represents and warrants that
the Undersigned has all necessary power and authority to execute this Agreement
and, if a director or executive officer of the Company, to cause the
Undersigned's Company Common Stock and any shares of Company Common Stock over
which the Undersigned has voting control, to be voted as provided herein, and
the Undersigned has duly authorized, executed and delivered this Agreement.
(b) This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware without giving effect to the principles
of conflict of laws thereof.
(c) This Agreement may be executed in any number of counterparts, all
of which taken together shall constitute one and the same instrument, and any
and all of the parties hereto may execute this Agreement by signing any such
counterpart.
(d) This Agreement shall terminate upon the earlier to occur of (i)
the Effective Date or (ii) termination of the Merger Agreement in accordance
with the terms thereof; provided, however, that Sections 5 and 7 shall survive
-------- -------
the termination of this Agreement if the Agreement is terminated pursuant to
clause (i) above.
(e) This agreement shall be binding on the Undersigned's successors
and assigns, including his heirs, executors and administrators.
(f) The undersigned has carefully read this agreement and discussed
its requirements, to the extent the Undersigned believed necessary, with its
counsel or counsel for the Company or the Parent.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed as of the date first above written.
LERNOUT & HAUSPIE SPEECH PRODUCTS N.V.
By:____________________________
Name:
Title:
STOCKHOLDER:
_________________________________